Author: Talawar Therapeutics

Talawar Therapeutics Appoints Steve Migausky as Chief Legal and Administrative Officer

July 20, 2026
Talawar Therapeutics and JATT II Acquisition Corp. Announce Definitive Business Combination Agreement to Create Publicly Listed Biotechnology Company Developing Potentially Best-in-Class Bispecifics for I&I Diseases

June 29, 2026

Talawar Therapeutics Appoints Steve Migausky as Chief Legal and Administrative Officer